Genentech - A Member of the Roche Group

Journeys: Bob Cohen

Genentech scientist Bob Cohen chose to shift from practicing oncology to researching new treatment options for cancer patients. This is science in the pursuit of patient care.

You Might Also Be Interested In

Our Pipeline

The Genentech Research and Early Development pipeline has 30 new molecular entities in clinical development.

Taking Science Personally

Our scientists discuss their rigorous approach to breakthrough science.

Feedback?

Tell us what you think about our company, products, or website.

“
The way to do research is to attack the facts at the point of greatest astonishment.
” – Celia Green
Connect with us